The company is now hanging on a business plan constructed by Marketing and Reimbursement. Senior Management is all in on gaining a NOS code for EX. This will be next to impossible with the clinical data they have collected with TEMPO. The EX "procedure" will have to show clinically significant results when compared to an existing procedure to gain proper reimbursement. TEMPO is a good study, but fails to compare TIF to Nissen or other reflux procedures. Because of this, gaining the attention of the AMA to have them recommend a new code will be next to impossible. The VP of reimbursement should understand- but obviously doesn't. My guess is the he is getting advice from the Director of Marketing.
EX is a great device, but Senior staff has has put the entire company at risk by not recognizing that it is a device. They have compromised the careers of all employees- past and present. This is a lack of understand the medical device market and the healthcare industry. The VP's of Sales have merely been pawns under this management team and the prior management team. Personally, I find Sr Management negligent and hold them responsible for the failure of EGS. Happy Holidays!